Bio Symetrics, Inc. announced it raised $4.88 Million in an initial filing from an offering of $5.85 Million
Bio Symetrics, Inc. announced it raised $4.88 Million in an initial filing from an offering of $5.85 Million
08/04/21, 1:54 PM
Location
huntingtonMoney raised
$4.88 million
Industry
biotechnology
Round Type
seed
Company Info
Location
315 main street
huntington, new york, united states
Additional Info
BioSymetrics innovative Elion™ platform uses in silico artificial
intelligence and in vivo clinical research to reduce costs and improve
results at every stage drug discovery. Patent pending Contingent AI and a
unique phenograph of human (EMR) and animal phenotype data improve hit
identification and lead progression. BioSymetrics is Drug Discovery
Accelerated.